Jignesh H. Patel, PharmD, BSc

Clinical Specialist, Trauma/Burn Surgery Jignesh Patel

Education: PharmD, Chicago College of Pharmacy, Midwestern University. B.Sc: Eugene Applebaum College of Pharmacy, Wayne State University.

Residency Training: Pharmacy Practice Residency, Detroit Medical Center, Detroit, MI.

Fellowship Training: University of Michigan, College of Pharmacy, Ann Arbor, MI.

Faculty Appointments: Wegmans School of Pharmacy, St. John Fisher College, Rochester, NY. School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, NY

Practice Area: Trauma/Burn Surgery http://www.urmc.rochester.edu/burn-trauma/

Publications: Kahn SA, Patel JH, Lentz CW, Bell DE. Firefighter Burn Injuries: Predictable Patterns Influenced by Turn Gear. J Burn Care Res 2011 (In Press); Vilay AM, Shah KH, Churchwell MD, Patel JH, DePestel DD, Mueller BA. Modeled Dalbavancin Transmembrane Clearance During Intermittent and Continuous Renal Replacement Therapies. Blood Purif. 2010 June:30(1):37-43; Salama NN, Segal J, Churchwell MD, Patel JH, Gao L, Heung M, Mueller BA. Single-Dose Daptomycin Pharmacokinetics in Chronic Hemodialysis Patients. Nephrol Dial Transplant. 2010 Apr;25(4):1279-84; Patel JH, Churchwell MD, Seroogy JD, Barriere SL, Grio M, Mueller BA. Telavancin and Hydroxy Propyl-Beta-Cyclodextrin Clearance During Continuous Renal Replacement Therapy: An in vitro Study. Int J Artif Organs. 2009 Oct;32(10):745-51; Lockhart CA, Patel JH, Lee W. Novel Targets in Esophageal and Gastric Cancer: Beyond Antiangiogenesis. Expert Opin Investig Drugs. 2009 Sep;18(9):1351-64; Salama NN, Segal J, Churchwell MD, Patel JH, Gao L, Heung M, Mueller BA. Intradialytic Administration of Daptomycin in End Stage Renal Disease (ESRD) Patients on Hemodialysis. Clin J Am Soc Nephrol. 2009 Jul;4(7):1190-4; Stevenson JM, Patel JH, Vilay AM, Churchwell MD, DePestel DD, Sorgel F, Kinzig-Schippers M. Mueller BA. Ertapenem Transmembrane Clearance During Modeled Continuous Renal Replacement Therapy. Int J Artif Organs. 2008 Dec;31(12):1027-34; Abstracts, Published: Kahn SA, Patel JH, Bell DE. Firefighter Burn Injuries: Predictable Patterns Influenced by Turn Gear. J Burn Care Res 2011;32(2) (Suppl): S104 (Abstract #108); Salama NN, Nielsen J, Stout SM, Patel JH, Welage LS. Disease Associated Changes in P-glycoprotein in Acute Inflammation. American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, November 2009. (Abstract 746: The AAPS Journal); Mueller BA, Shah KH, Patel JH, DePestel DD, Vilay AM. Dalbavancin Transmembrance Clearance During Modeled Continuous Hemofiltration. Blood Purif 2009;27(3):301 (Abstract #65); Salama NN, Segal J, Churchwell MD, Patel JH, Gao L, Heung M, Mueller BA. Daptomycin Serum Concentrations are Maintained in a 2 and 3-Day Intradialytic Period. Poster # SA-PO2772. Journal of the American Society of Nephrology (JASN). J Am Soc Nephrol 2008, 19:737A; Salama NN, Segal J, Churchwell MD, Patel JH, Gao L, Heung M, Mueller BA. Intradialytic Administration of Daptomycin in End Stage Renal Disease (ESRD) Patients. Poster # SA-PO2773. Journal of the American Society of Nephrology (JASN). J Am Soc Nephrol 2008, 19:738A; Vilay AM. Stevenson JM, Churchwell MD, Patel JH, DePestel DD, Sorgel F, Kinzig-Schippers M. Mueller BA. Ertapenem Transmembrane Clearance During Modeled Continuous Hemofiltration. Blood Purif 2008;26:172-3; Vilay AM. Stevenson JM, Churchwell MD, Patel JH, DePestel DD, Sorgel F, Kinzig-Schippers M. Mueller BA. Ertapenem Transmembrane Clearance During Modeled Continuous Hemodialysis. Blood Purif 2008;26:173; Salama NN, Nielsen J, Patel JH, Welage LS. Decreased Hepatic P-Glycoprotein Expression in Endotoxin-Induced Acute Inflammation. Crit Care Med, 2007 35, (12) (Suppl): A37; Patel JH, Churchwell MD, Seroogy JD, Barriere S, Mueller BA. 2-Hydroxypropyl Beta Cyclodextrin Transmembrane Clearance During In Vitro Continuous Venovenous Hemodialysis (Abstract 51). Pharmacother 2007; 27(4): e17; Welage LS, Nielsen JC, Patel JH, An MS, Bush AR. Effect of Endotoxin on Hepatic Mdr1a Gene Expression in Rats. Poster # 132. Crit Care Med, 2006; 34(12) (Suppl):A32; Patel JH, Mueller BA, Levy S, Brown J, Lamp KC. Efficacy and Safety of Daptomycin in Patients Receiving Hemodialysis – A Retrospective Review. Poster # SA-PO328. Journal of the American Society of Nephrology (JASN), November 2006;17:645A; Patel JH, Mueller BA, Levy S, Brown J, Lamp KC. Experience from a Registry for Daptomycin and Continuous Renal Replacement Therapy. Journal of the American Society of Nephrology (JASN), November 2006;17:916A; Grio MC, Patel JH, Mueller BA. University of Michigan Experience in Patients Receiving Simultaneous Daptomycin and Continuous Venovenous Hemodialysis. Journal of the American Society of Nephrology (JASN), November 2006;17:884A; Patel JH, Grio M, Churchwell MD, Seroogy J, Barriere S, Mueller BA. Hydroxypropyl Beta Cyclodextrin Transmembrane Clearance During In Vitro Continuous Venovenous Hemofiltration (CVVH). Poster #46. Blood Purif 2006;24:267; Patel JH, Grio M, Churchwell MD, Seroogy J, Barriere S, Mueller BA. Telavancin Transmembrane Clearance During In Vitro Continuous Venovenous Hemofiltration (CVVH). Poster #1538. Clinical Microbiology and Infection;12(9) (suppl), Apr 2006. (Electronic version); Patel JH, Grio M, Churchwell MD, Seroogy J, Barriere S, Mueller BA. Telavancin Transmembrane Clearance During In Vitro Continuous Venovenous Hemodialysis (CVVHD). Poster #1539. Clinical Microbiology and Infection;12(9 suppl), Apr 2006. (electronic version).

Email: jignesh_patel@urmc.rochester.edu